Literature DB >> 17416818

Defining optic nerve tortuosity.

G T Armstrong1, A R Localio, T Feygin, L Bilaniuk, P C Phillips, M J Fisher, B L Strom, R Zimmerman.   

Abstract

BACKGROUND AND
PURPOSE: Optic nerve tortuosity is one of several nonmalignant abnormalities documented on MR imaging in patients with neurofibromatosis type 1 and may be related to the development of optic pathway gliomas. This study seeks an operational definition for optic nerve tortuosity.
MATERIALS AND METHODS: A focus group of 3 pediatric neuroradiologists reviewed 20 MR images of the brain and orbits of patients suspected to have optic nerve tortuosity in the absence of optic pathway glioma and found 6 radiographic factors that occurred frequently. Subsequently, 28 MR images were assessed for the presence of optic nerve tortuosity, using a global assessment question that reflects a neuroradiologist's confidence in the presence of optic nerve tortuosity, and for the presence of the 6 radiographic factors, to identify a combination of these factors that best predicted a diagnosis of optic nerve tortuosity.
RESULTS: We found perfect inter-rater agreement between 3 readers on the presence/absence of tortuosity in 75% of cases. Lack of congruity of the optic nerves, in more than 1 coronal section and dilation of the subarachnoid space surrounding the optic nerves, when found together are sensitive (89%) and specific (93%) for a diagnosis of tortuosity on the global scale. The absence of these 2 factors, along with absence of deviation of the optic nerve within the axial plane, provides a reliable test to exclude tortuosity.
CONCLUSION: Lack of congruity of the optic nerves in more than 1 coronal section and dilation of the subarachnoid space surrounding the optic nerves together provide an operational radiographic definition of optic nerve tortuosity.

Entities:  

Mesh:

Year:  2007        PMID: 17416818      PMCID: PMC7977357     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

1.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

Review 2.  MRI diagnosis of NF-1 in children without café-au-lait skin lesions.

Authors:  R G Curless; M Siatkowski; J S Glaser; N J Shatz
Journal:  Pediatr Neurol       Date:  1998-03       Impact factor: 3.372

3.  Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.

Authors:  R Raininko; L Thelin; O Eeg-Olofsson
Journal:  Neuropediatrics       Date:  2001-10       Impact factor: 1.947

4.  Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.

Authors:  L J Balcer; G T Liu; G Heller; L Bilaniuk; N J Volpe; S L Galetta; P T Molloy; P C Phillips; A J Janss; S Vaughn; M G Maguire
Journal:  Am J Ophthalmol       Date:  2001-04       Impact factor: 5.258

5.  Neurofibromatosis types 1 and 2: cranial MR findings.

Authors:  S Aoki; A J Barkovich; K Nishimura; B O Kjos; T Machida; P Cogen; M Edwards; D Norman
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

6.  Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.

Authors:  F Menor; L Marti-Bonmati; E Arana; C Poyatos; H Cortina
Journal:  Eur J Radiol       Date:  1998-01       Impact factor: 3.528

7.  Defining the clinically important difference in pain outcome measures.

Authors:  J T Farrar; R K Portenoy; J A Berlin; J L Kinman; B L Strom
Journal:  Pain       Date:  2000-12-01       Impact factor: 6.961

8.  The minimum clinically important difference in physician-assigned visual analog pain scores.

Authors:  K H Todd; J P Funk
Journal:  Acad Emerg Med       Date:  1996-02       Impact factor: 3.451

9.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

10.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; M J Greenwald; N B Esterly
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

View more
  5 in total

1.  Quantitative magnetic resonance image assessment of the optic nerve and surrounding sheath after spaceflight.

Authors:  Jesse J Rohr; Stuart Sater; Austin M Sass; Karina Marshall-Goebel; Robert J Ploutz-Snyder; C Ross Ethier; Michael B Stenger; Bryn A Martin; Brandon R Macias
Journal:  NPJ Microgravity       Date:  2020-10-08       Impact factor: 4.415

2.  Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.

Authors:  Robert A Avery; Awais Mansoor; Rabia Idrees; Elijah Biggs; Mohammad Ali Alsharid; Roger J Packer; Marius George Linguraru
Journal:  Neurology       Date:  2016-05-11       Impact factor: 9.910

3.  MRI findings differentiating tonsillar herniation caused by idiopathic intracranial hypertension from Chiari I malformation.

Authors:  Seyed Amir Ebrahimzadeh; Elizabeth Du; Yu-Ming Chang; Marc Bouffard; Francis Loth; Rafeeque A Bhadelia
Journal:  Neuroradiology       Date:  2022-06-14       Impact factor: 2.995

4.  Optic nerve tortuosity in children with neurofibromatosis type 1.

Authors:  Joyce Ji; Joshua Shimony; Feng Gao; Robert C McKinstry; David H Gutmann
Journal:  Pediatr Radiol       Date:  2013-05-02

5.  Quantitative magnetic resonance image assessment of the optic nerve and surrounding sheath after spaceflight.

Authors:  Jesse J Rohr; Stuart Sater; Austin M Sass; Karina Marshall-Goebel; Robert J Ploutz-Snyder; C Ross Ethier; Michael B Stenger; Bryn A Martin; Brandon R Macias
Journal:  NPJ Microgravity       Date:  2020-10-08       Impact factor: 4.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.